Results From a Phase II Trial of Reldesemtiv For Treating Spinal Muscular Atrophy Have Been Announced
rawpixel / Pixabay

Results From a Phase II Trial of Reldesemtiv For Treating Spinal Muscular Atrophy Have Been Announced

Data from a Phase II clinical trial of the experimental treatment reldesemtiv for the treatment of spinal muscular atrophy has been announced. The drug has shown positive effects in the…

Continue Reading Results From a Phase II Trial of Reldesemtiv For Treating Spinal Muscular Atrophy Have Been Announced

Interim Data From a Study of a Sickle Cell Disease Gene Therapy Has Been Announced

The experimental gene therapy LentiGlobin for the treatment of severe sickle cell disease is being investigated in an ongoing Phase 1 clinical trial. Bluebird Bio, the company developing the therapy,…

Continue Reading Interim Data From a Study of a Sickle Cell Disease Gene Therapy Has Been Announced
Partnership Will Allow The Development of New Drug For Dystrophic Epidermolysis Bullosa
rawpixel / Pixabay

Partnership Will Allow The Development of New Drug For Dystrophic Epidermolysis Bullosa

According to a story from pm360online.com, the drug development company ProQR Therapeutics N.V. will be partnering with EB Research Partnership (EBRP) and EB Medical Research Foundation (EBMRF) in order to…

Continue Reading Partnership Will Allow The Development of New Drug For Dystrophic Epidermolysis Bullosa
Dad Plans to Promote Awareness About Cystinosis, His Daughter’s Rare Disease as Father’s Day Approaches
https://pixabay.com/en/father-daughter-beach-family-daddy-656734/

Dad Plans to Promote Awareness About Cystinosis, His Daughter’s Rare Disease as Father’s Day Approaches

According to a story from CBS News, Clay Emerson, from New Jersey, is hoping to use Father's Day in order to raise awareness about his three year old daughter's rare…

Continue Reading Dad Plans to Promote Awareness About Cystinosis, His Daughter’s Rare Disease as Father’s Day Approaches

Investigational Drug For Limbal Stem Cell Deficiency Gets Orphan Drug Designation

According to a story from pm360online.com, the speciality pharmaceutical company Chiesi USA and the biotech company Holostem Terapie Avanzate S.r.l. of Italy recently announced that the U.S. FDA recently granted orphan…

Continue Reading Investigational Drug For Limbal Stem Cell Deficiency Gets Orphan Drug Designation

A Nigerian Mother Writes Heart-Melting Eulogy for Deceased Daughter Who Died of Hodgkin Lymphoma

A Nigerian mother, Hafsat Aliyu has penned a moving tribute to her beautiful daughter, Zainab, who died of Hodgkin lymphoma, a type of blood cancer, on May 7, 2015. She…

Continue Reading A Nigerian Mother Writes Heart-Melting Eulogy for Deceased Daughter Who Died of Hodgkin Lymphoma
Medical Research Network is Improving Clinical Trials
https://pixabay.com/en/hospital-ward-hospital-medical-room-1338585/

Medical Research Network is Improving Clinical Trials

Medical Research Network (MRN) is an organisation that specialises in the conduct of clinical trial visits in the patient’s home and supporting clinical trial sites with nursing resources. MRN aims…

Continue Reading Medical Research Network is Improving Clinical Trials
Express Scripts Makes Diagnosis Easier with Second Opinion
Source: Pixabay

Express Scripts Makes Diagnosis Easier with Second Opinion

According to PRNewswire, Express Scripts announced a new program to benefit people living with rare diseases on May 31st. The program, called Second Opinion is part of the company’s larger…

Continue Reading Express Scripts Makes Diagnosis Easier with Second Opinion